Sequent Scientific Profile
Key Indicators
- Authorised Capital ₹ 80.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 49.93 Cr
as on 15-11-2024
- Company Age 39 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 423.00 Cr
as on 15-11-2024
- Satisfied Charges ₹ 1,638.84 Cr
as on 15-11-2024
- Revenue 1.48%
(FY 2023)
- Profit -141.08%
(FY 2023)
- Ebitda -3414.67%
(FY 2023)
- Net Worth 1.66%
(FY 2023)
- Total Assets -0.13%
(FY 2023)
About Sequent Scientific
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 512529 and on the National Stock Exchange(NSE) under EQUENT.
The Corporate was formerly known as Visistha Trades & Finance Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 80.00 Cr and a paid-up capital of Rs 49.93 Cr.
The company currently has active open charges totaling ₹423.00 Cr. The company has closed loans amounting to ₹1,638.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sequent Scientific Limited India are Phillip Trott as COMPANY SECRETARY and Saurav Bhala as Cfo. Neeraj Bharadwaj, Rajaram Narayanan, Kausalya Santhanam, and Six other members serve as directors at the Company.
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sequent Scientific Limited offer?
Sequent Scientific Limited offers a wide range of products and services, including Veterinary Injections, Ivermectin Injection, Pharmaceutical Services, Animal Medicines & Health Care, Animal Treatment Services, Content Writing Service, Research Development Services, Pharma & Bioanalytical Services.
Who are the key members and board of directors at Sequent Scientific?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajaram Narayanan  | Managing Director | 11-Apr-2022 | Current |
| Phillip Trott | Company Secretary | 07-Mar-2024 | Current |
| Saurav Bhala | CFO | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Milind Sarwate | Director | 25-Aug-2020 | Current |
| Kausalya Santhanam | Director | 28-Oct-2014 | Current |
| Kamal Sharma | Director | 25-Aug-2020 | Current |
Gregory Andrews  | Director | 06-Nov-2020 | Current |
Neeraj Bharadwaj  | Director | 17-Aug-2020 | Current |
| Fabian Kausche | Director | 14-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Sequent Scientific.
Sequent Scientific Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.48% increase. The company also saw a substantial fall in profitability, with a 141.08% decrease in profit. The company's net worth moved up by a moderate rise of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sequent Scientific?
In 2016, Sequent Scientific had a promoter holding of 56.25% and a public holding of 43.75%. The company had 7 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Foundation For Promotion Of Sports And GamesActive 23 years 2 monthsNeeraj Bharadwaj is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Apr 2024 | ₹360.00 Cr | Open |
Others Creation Date: 27 Dec 2023 | ₹15.00 Cr | Open |
Others Creation Date: 27 Dec 2023 | ₹10.00 Cr | Open |
How Many Employees Work at Sequent Scientific?
Sequent Scientific has a workforce of 399 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sequent Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequent Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
